Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Eli Lilly and Company

Holley ( ($HLLY) ) has shared an update. On December 10, 2025, Holley Inc. amended the employment agreement with its President and CEO, Matthew Ste...

Holley Amends CEO Employment Agreement for 2026

The pharma giant has high hopes for the medication. 


Eli Lilly’s (LLY) Newest Weight-Loss Drug Delivers Strong Results in Late-Stage Trial

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co, with a price target of $1,200.00. Bansal c...

Wells Fargo Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

The obesity treatment space has been generating plenty of headlines – and sales – over the past few years. GLP-1 receptor agonists such as semaglut...

LLY and NOVO: Goldman Sachs Weighs In on the Top Obesity Stocks to Watch in 2026

Earnings reports, analyst updates, and other economic news are among the top stock market stories for Wednesday.


Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!

The pharma giant is racing to bring a weight-loss pill to market. 


Eli Lilly (LLY) to Build New $6 Billion Manufacturing Plant in Alabama

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will also include the offic...

Hims & Hers Health (HIMS) Bolsters UK Business with Launch of Weight-Loss Plans

Biotech Structure Therapeutics’ ($GPCR) shares rallied 102.49% on Monday after mid-stage data for its obesity pill topped competing offerings from ...

Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk

The award-winning researcher was previously at Eli Lilly from 2017-2021.


Nobel Prize-Winning Chemist Carolyn Bertozzi Rejoins Eli Lilly’s (LLY) Board of Directors

Shares of Texas-based biotech firm iBio ($IBIO) have climbed as high as 50% over the past 24 hours. This follows a 39.17% gain on Monday and an add...

Why is Biotech Stock iBio Up over 50%?

The distribution increase comes as weight-loss drug sales surge. 


Eli Lilly (LLY) Raises Dividend by 15%

Morgan Stanley analyst Terence Flynn maintained a Buy rating on Eli Lilly & Co on December 5 and set a price target of $1,290.00. The company’s sha...

Morgan Stanley Remains a Buy on Eli Lilly & Co (LLY)

The share price has rallied over the past month.


Eli Lilly Stock (LLY) Gets Multiple Price Target Increases as Rally Continues

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acadia Healthcare (ACHC – Research Report) and Eli L...

Analysts Are Bullish on These Healthcare Stocks: Acadia Healthcare (ACHC), Eli Lilly & Co (LLY)

Berenberg Bank analyst Kerry Holford maintained a Hold rating on Eli Lilly & Co yesterday and set a price target of $950.00. According to TipRanks,...

Berenberg Bank Reaffirms Their Hold Rating on Eli Lilly & Co (LLY)

Access to weight-loss drugs is broadening out. 


BMO Capital Markets Reiterates Buy Rating on Eli Lilly Stock (LLY)

British drugmaker AstraZeneca ($AZN), fresh off a record-high stock price, continues to draw interest from U.S. and European investors thanks to, a...

Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?

The company has agreed to make its medications more affordable. 


Eli Lilly (LLY) Lowers Price of Weight-Loss Drug on Direct-to-Consumer Site

Shares in weight-loss jab firms Novo Nordisk ($NVO) and Eli Lilly ($LLY) looked a little thinner today as the World Health Organization (WHO) decla...

NVO,LLY: Shares Drop as Word Health Organization Calls for Cheaper Versions of Weight-Loss Drugs

Insiders have been trading these 5 stocks: (($LLY)), (($MSTR)), (($AMAT)), (($RKLB)) and (($QS)). Here is a breakdown of their recent trades and th...

Eli Lilly, Strategy, Applied Materials, Rocket Lab, and QuantumScape: Insider Moves Unveiled

Expectations are high for the company’s weigh-loss pill. 


Eli Lilly Stock (LLY) Rose 30% in November

The money is used for charitable causes. 


Eli Lilly’s (LLY) Endowment Becomes the Largest in the U.S. with $100 Billion of Assets

The pharma giant has a strong pipeline of medications. 


JPMorgan Analyst Pounds the Table on Eli Lilly Stock (LLY)

Shares of Novo Nordisk ($NVO) are up 3% at the time of writing after the Centers for Medicare & Medicaid Services (CMS) announced price cuts across...

Novo Nordisk Stock (NVO) Jumps after Ozempic and Wegovy Prices Cut 71% under Medicare Plan

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY – Research Report), AbSci (ABSI ...

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), AbSci (ABSI) and Praxis Precision Medicines (PRAX)

Jarden analyst Steven Wheen maintained a Buy rating on CSL on November 22 and set a price target of A$283.00. Wheen covers the Healthcare sector, f...

Jarden Sticks to Its Buy Rating for CSL (CMXHF)

Traders will find all of the deals, analyst ratings, and government updates moving shares on Monday in our daily roundup.


Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!

Everything to Know about Macro and Markets U.S. stocks ended the week mixed as investors balanced strong corporate earnings with renewed volatility...

The Week That Was, The Week Ahead: Macro & Markets, November 23, 2025

Bristol Gate Capital Partners Inc., managed by Richard Hamm, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). ...

Bristol Gate Capital Reduces Stake in Eli Lilly

Gamco Investors, Inc. ET AL, managed by Mario Gabelli, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The he...

Gamco Investors Reduces Stake in Eli Lilly

Viking Global Investors LP, managed by Andreas Halvorsen, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The...

Viking Global Investors LP Reduces Stake in Eli Lilly

Maverick Capital ltd, managed by Lee Ainslie, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge fund ...

Maverick Capital Ltd Reduces Stake in Eli Lilly

Fisher Asset Management LLC, managed by Ken Fisher, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge...

Fisher Asset Management LLC Boosts Stake in Eli Lilly

PRIMECAP Management Co, managed by Theofanis Kolokotrones, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). Th...

PRIMECAP Management Co Reduces Stake in Eli Lilly

Chilton Investment Co LLC, managed by Richard Chilton, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The he...

Chilton Investment Co LLC Boosts Stake in Eli Lilly

Driehaus Capital Management LLC, managed by Richard Driehaus, recently executed a significant transaction involving Eli Lilly And Company (($LLY))....

Driehaus Capital Reduces Stake in Eli Lilly

Coatue Management, LLC, managed by Philippe Laffont, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedg...

Coatue Management Reduces Stake in Eli Lilly

MIG Capital, Llc, managed by Richard Merage, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge fund r...

MIG Capital Reduces Stake in Eli Lilly

Woodline Partners LP, managed by Michael Rockefeller, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hed...

Woodline Partners LP Boosts Stake in Eli Lilly

Duquesne Family Office LLC, managed by Stanley Druckenmiller, recently executed a significant transaction involving Eli Lilly And Company (($LLY))....

Duquesne Family Office LLC Reduces Eli Lilly Stake

SCS Capital Management LLC, managed by Antony J. Abbiati, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The...

SCS Capital Management LLC Reduces Stake in Eli Lilly

Blackstone Inc., managed by Stephen A. Schwarzman, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge ...

Blackstone Inc. Boosts Stake in Eli Lilly

Gilder Gagnon Howe & Co LLC., managed by Travis Knapp Anderson, recently executed a significant transaction involving Eli Lilly And Company (($LLY)...

Gilder Gagnon Howe Reduces Stake in Eli Lilly

Moore Capital Management LP, managed by Louis Moore Bacon, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). Th...

Moore Capital Management LP Reduces Stake in Eli Lilly

Tiger Global Management LLC, managed by Chase Coleman, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The he...

Tiger Global Reduces Stake in Eli Lilly

Mairs & Power Inc, managed by Bill Frels, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge fund redu...

Mairs & Power Inc Reduces Stake in Eli Lilly

Bridgewater Associates, LP, managed by Ray Dalio, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge f...

Bridgewater Associates Boosts Stake in Eli Lilly

Dodge & Cox, managed by John A. Gunn, recently executed a significant transaction involving Eli Lilly And Company (($LLY)). The hedge fund reduced ...

Dodge & Cox Reduces Stake in Eli Lilly

Insiders have been trading these 5 stocks: (($F)), (($KO)), (($GE)), (($LLY)) and (($ET)). Here is a breakdown of their recent trades and their val...

Ford, Coca-Cola, GE, Eli Lilly, Energy Transfer: Insider Moves Unveiled!

Eli Lilly & Co ( ($LLY) ) has provided an update. On November 18, 2025, Eli Lilly & Co announced the election of Dr. Carolyn R. Bertozzi to its Board


Eli Lilly Announces New Board Member Election

Earnings reports, acquisitions, and other news are leading the top stock market stories for Friday.


Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!

Shares of Danish pharmaceutical Novo Nordisk ($NVO) traded flat on Friday afternoon after its key U.S.-based rival Eli Lilly ($LLY) reached $1 tril...

Novo Nordisk Stock (NVO) Under Pressure as Rival Eli Lilly Joins the $1 Trillion Club

U.S. pharmaceutical giant Eli Lilly & Co. ($LLY) has become the latest company to achieve a $1 trillion market capitalization. The milestone was re...

Eli Lilly Stock (LLY) Surpasses $1 Trillion Market Cap

Eli Lilly (NYSE:LLY) shares have climbed about 22% this month, a trend that has become a regular occurrence of late. Since bottoming out in early A...

‘A Bigger Market Opportunity Awaits,’ Says Truist About Eli Lilly Stock

Several high-profile stocks have split in recent years. 


Will Eli Lilly Stock (LLY) Split? Rumors Are Swirling.

All of the top stock market stories are ready to go in the TipRanks daily wrap-up.


Eli Lilly Stock (LLY) Falls as Rival Novo Nordisk Cuts Weight-Loss Drug Prices

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on MetroCity Bankshares (MCBS – Research Report), Jeff...

Analysts Conflicted on These Financial Names: MetroCity Bankshares (MCBS), Jefferson Capital, Inc. (JCAP) and Ally Financial (ALLY)

Insiders have been trading these 5 stocks: (($LLY)), (($GM)), (($IONQ)), (($MRK)) and (($MARA)). Here is a breakdown of their recent trades and the...

Eli Lilly, GM, IonQ, Merck, MARA: Insider Moves Unveiled!

Analysts are intrested in these 5 stocks: ( ($JD) ), ( ($LLY) ), ( ($CCJ) ), ( ($COIN) ) and ( ($MSTR) ). Here is a breakdown of their recent


JD, Eli Lilly, Cameco, Coinbase, and Strategy: Trending by Analysts

Investors continued to dump shares of telehealth company Mangoceuticals ($MGRX) during early trading on Friday. This came after pharmaceutical heav...

Investors Flee Mangoceuticals Stock (MGRX) after Eli Lilly and Novo Nordisk Deny Partnership

Hims & Hers Health’s ($HIMS) shares continued to plunge on Thursday despite the consumer telehealth company launching a new “affordable” healthcare...

Hims & Hers Stock (HIMS) Plunges despite New ‘Affordable’ Healthcare Platform

Traders will find all of the latest stock market stories worth reading about on Thursday in our daily wrap-up.


Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

Pfizer’s shares ($PFE) edged higher on Thursday after shareholders of Metsera ($MTSR) approved the American pharma giant’s offer of up to $10 billi...

Pfizer Stock (PFE) Rises as Metsera Shareholders Approve $10B Acquisition

The upcoming weight-loss pill is expected to be a gamechanger. 


Citigroup Sees 50% Upside in Eli Lilly Stock (LLY)

Multiple catalysts are driving the share price higher. 


	A	B	C	D
1	Symbol	Price	Change	Volume
2	LLY	$1,009.38	+1.58%	3.34M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LLY	$1,009.38	+1.6%	3.34M
3
4
5
6

LLY

LLY

Get Eli Lilly and Company Data in Excel

Get Eli Lilly and Company Data in Excel